UniProt ID | K1C19_HUMAN | |
---|---|---|
UniProt AC | P08727 | |
Protein Name | Keratin, type I cytoskeletal 19 | |
Gene Name | KRT19 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 400 | |
Subcellular Localization | ||
Protein Description | Involved in the organization of myofibers. Together with KRT8, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.. | |
Protein Sequence | MTSYSYRQSSATSSFGGLGGGSVRFGPGVAFRAPSIHGGSGGRGVSVSSARFVSSSSSGAYGGGYGGVLTASDGLLAGNEKLTMQNLNDRLASYLDKVRALEAANGELEVKIRDWYQKQGPGPSRDYSHYYTTIQDLRDKILGATIENSRIVLQIDNARLAADDFRTKFETEQALRMSVEADINGLRRVLDELTLARTDLEMQIEGLKEELAYLKKNHEEEISTLRGQVGGQVSVEVDSAPGTDLAKILSDMRSQYEVMAEQNRKDAEAWFTSRTEELNREVAGHTEQLQMSRSEVTDLRRTLQGLEIELQSQLSMKAALEDTLAETEARFGAQLAHIQALISGIEAQLGDVRADSERQNQEYQRLMDIKSRLEQEIATYRSLLEGQEDHYNNLSASKVL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTSYSYRQS ------CCCCCCCCC | 36.05 | 24719451 | |
3 | Phosphorylation | -----MTSYSYRQSS -----CCCCCCCCCC | 15.69 | 28857561 | |
4 | Phosphorylation | ----MTSYSYRQSSA ----CCCCCCCCCCC | 10.68 | 28857561 | |
5 | Phosphorylation | ---MTSYSYRQSSAT ---CCCCCCCCCCCC | 17.38 | 24719451 | |
6 | Phosphorylation | --MTSYSYRQSSATS --CCCCCCCCCCCCC | 12.39 | 28857561 | |
7 | Dimethylation | -MTSYSYRQSSATSS -CCCCCCCCCCCCCC | 24.78 | - | |
7 | Methylation | -MTSYSYRQSSATSS -CCCCCCCCCCCCCC | 24.78 | 24129315 | |
9 | Phosphorylation | TSYSYRQSSATSSFG CCCCCCCCCCCCCCC | 16.97 | 23911959 | |
10 | Phosphorylation | SYSYRQSSATSSFGG CCCCCCCCCCCCCCC | 27.51 | 23911959 | |
12 | Phosphorylation | SYRQSSATSSFGGLG CCCCCCCCCCCCCCC | 27.18 | 30278072 | |
13 | Phosphorylation | YRQSSATSSFGGLGG CCCCCCCCCCCCCCC | 24.32 | 28355574 | |
14 | Phosphorylation | RQSSATSSFGGLGGG CCCCCCCCCCCCCCC | 24.45 | 28355574 | |
22 | Phosphorylation | FGGLGGGSVRFGPGV CCCCCCCCCEECCCE | 17.25 | 28355574 | |
24 | Asymmetric dimethylarginine | GLGGGSVRFGPGVAF CCCCCCCEECCCEEE | 32.28 | - | |
24 | Methylation | GLGGGSVRFGPGVAF CCCCCCCEECCCEEE | 32.28 | 24129315 | |
32 | Methylation | FGPGVAFRAPSIHGG ECCCEEEECCCCCCC | 35.53 | 24129315 | |
35 | Phosphorylation | GVAFRAPSIHGGSGG CEEEECCCCCCCCCC | 26.66 | 27273156 | |
40 | Phosphorylation | APSIHGGSGGRGVSV CCCCCCCCCCCCCCC | 42.54 | 28355574 | |
43 | Dimethylation | IHGGSGGRGVSVSSA CCCCCCCCCCCCCCE | 45.96 | - | |
43 | Methylation | IHGGSGGRGVSVSSA CCCCCCCCCCCCCCE | 45.96 | 24129315 | |
46 | Phosphorylation | GSGGRGVSVSSARFV CCCCCCCCCCCEEEE | 21.07 | 28355574 | |
48 | Phosphorylation | GGRGVSVSSARFVSS CCCCCCCCCEEEEEC | 15.69 | 28857561 | |
49 | Phosphorylation | GRGVSVSSARFVSSS CCCCCCCCEEEEECC | 22.70 | 28857561 | |
51 | Methylation | GVSVSSARFVSSSSS CCCCCCEEEEECCCC | 34.15 | 24129315 | |
54 | Phosphorylation | VSSARFVSSSSSGAY CCCEEEEECCCCCCC | 23.07 | 28152594 | |
55 | Phosphorylation | SSARFVSSSSSGAYG CCEEEEECCCCCCCC | 29.01 | 27273156 | |
56 | Phosphorylation | SARFVSSSSSGAYGG CEEEEECCCCCCCCC | 22.48 | 28152594 | |
57 | Phosphorylation | ARFVSSSSSGAYGGG EEEEECCCCCCCCCC | 34.44 | 26657352 | |
58 | Phosphorylation | RFVSSSSSGAYGGGY EEEECCCCCCCCCCC | 29.41 | 28152594 | |
61 | Phosphorylation | SSSSSGAYGGGYGGV ECCCCCCCCCCCCCE | 21.59 | 28152594 | |
65 | Phosphorylation | SGAYGGGYGGVLTAS CCCCCCCCCCEEECC | 17.62 | 28152594 | |
70 | Phosphorylation | GGYGGVLTASDGLLA CCCCCEEECCCCCCC | 23.00 | 28152594 | |
72 | Phosphorylation | YGGVLTASDGLLAGN CCCEEECCCCCCCCC | 27.29 | 26657352 | |
81 | Ubiquitination | GLLAGNEKLTMQNLN CCCCCCCCCCCCCHH | 53.94 | 21906983 | |
93 | Phosphorylation | NLNDRLASYLDKVRA CHHHHHHHHHHHHHH | 30.71 | 25106551 | |
94 | Phosphorylation | LNDRLASYLDKVRAL HHHHHHHHHHHHHHH | 17.20 | 26356563 | |
97 | Acetylation | RLASYLDKVRALEAA HHHHHHHHHHHHHHC | 30.90 | 24786549 | |
97 | Ubiquitination | RLASYLDKVRALEAA HHHHHHHHHHHHHHC | 30.90 | 21906983 | |
111 | Ubiquitination | ANGELEVKIRDWYQK CCCCEEEEEEHHHHH | 23.73 | 21906983 | |
116 | Phosphorylation | EVKIRDWYQKQGPGP EEEEEHHHHHCCCCC | 15.32 | 22817900 | |
118 | Methylation | KIRDWYQKQGPGPSR EEEHHHHHCCCCCCC | 41.34 | 24583695 | |
118 | Ubiquitination | KIRDWYQKQGPGPSR EEEHHHHHCCCCCCC | 41.34 | 21906983 | |
124 | Phosphorylation | QKQGPGPSRDYSHYY HHCCCCCCCCCHHHE | 43.64 | 28348404 | |
127 | Phosphorylation | GPGPSRDYSHYYTTI CCCCCCCCHHHEEEH | 9.02 | 28857561 | |
128 | Phosphorylation | PGPSRDYSHYYTTIQ CCCCCCCHHHEEEHH | 14.87 | 28857561 | |
130 | Phosphorylation | PSRDYSHYYTTIQDL CCCCCHHHEEEHHHH | 9.14 | 28857561 | |
131 | Phosphorylation | SRDYSHYYTTIQDLR CCCCHHHEEEHHHHH | 7.62 | 28857561 | |
132 | Phosphorylation | RDYSHYYTTIQDLRD CCCHHHEEEHHHHHH | 15.40 | 23312004 | |
133 | Phosphorylation | DYSHYYTTIQDLRDK CCHHHEEEHHHHHHH | 10.66 | 27251275 | |
140 | Ubiquitination | TIQDLRDKILGATIE EHHHHHHHHHCCEEE | 33.14 | 22817900 | |
145 | Phosphorylation | RDKILGATIENSRIV HHHHHCCEEECCEEE | 27.33 | 23312004 | |
149 | Phosphorylation | LGATIENSRIVLQID HCCEEECCEEEEEEE | 15.59 | 22985185 | |
167 | Phosphorylation | LAADDFRTKFETEQA CCHHHHHHHHHHHHH | 39.83 | 21406692 | |
168 | Sumoylation | AADDFRTKFETEQAL CHHHHHHHHHHHHHH | 36.63 | - | |
168 | Acetylation | AADDFRTKFETEQAL CHHHHHHHHHHHHHH | 36.63 | 27178108 | |
168 | Methylation | AADDFRTKFETEQAL CHHHHHHHHHHHHHH | 36.63 | 72594069 | |
168 | Sumoylation | AADDFRTKFETEQAL CHHHHHHHHHHHHHH | 36.63 | - | |
168 | Ubiquitination | AADDFRTKFETEQAL CHHHHHHHHHHHHHH | 36.63 | 21906983 | |
171 | Phosphorylation | DFRTKFETEQALRMS HHHHHHHHHHHHHHH | 36.21 | 21406692 | |
178 | Phosphorylation | TEQALRMSVEADING HHHHHHHHHHHCHHH | 15.46 | 24719451 | |
194 | Phosphorylation | RRVLDELTLARTDLE HHHHHHHHHHCCCHH | 19.14 | 24719451 | |
198 | Phosphorylation | DELTLARTDLEMQIE HHHHHHCCCHHHHHH | 39.05 | 20068231 | |
208 | Sumoylation | EMQIEGLKEELAYLK HHHHHHHHHHHHHHH | 61.06 | - | |
208 | Sumoylation | EMQIEGLKEELAYLK HHHHHHHHHHHHHHH | 61.06 | - | |
208 | Ubiquitination | EMQIEGLKEELAYLK HHHHHHHHHHHHHHH | 61.06 | 21906983 | |
213 | Phosphorylation | GLKEELAYLKKNHEE HHHHHHHHHHHCCHH | 31.51 | 21118733 | |
215 | Sumoylation | KEELAYLKKNHEEEI HHHHHHHHHCCHHHH | 38.56 | - | |
215 | Sumoylation | KEELAYLKKNHEEEI HHHHHHHHHCCHHHH | 38.56 | - | |
215 | Ubiquitination | KEELAYLKKNHEEEI HHHHHHHHHCCHHHH | 38.56 | 21906983 | |
216 | Ubiquitination | EELAYLKKNHEEEIS HHHHHHHHCCHHHHH | 62.02 | 21906983 | |
223 | Phosphorylation | KNHEEEISTLRGQVG HCCHHHHHHHCCCCC | 25.35 | 24719451 | |
224 | Phosphorylation | NHEEEISTLRGQVGG CCHHHHHHHCCCCCC | 26.57 | 23312004 | |
234 | Phosphorylation | GQVGGQVSVEVDSAP CCCCCEEEEEEECCC | 12.50 | 26657352 | |
239 | Phosphorylation | QVSVEVDSAPGTDLA EEEEEEECCCCCCHH | 41.35 | 28348404 | |
243 | Phosphorylation | EVDSAPGTDLAKILS EEECCCCCCHHHHHH | 27.12 | 22468782 | |
247 | Ubiquitination | APGTDLAKILSDMRS CCCCCHHHHHHHHHH | 52.02 | 21906983 | |
250 | Phosphorylation | TDLAKILSDMRSQYE CCHHHHHHHHHHHHH | 32.60 | 24719451 | |
254 | Phosphorylation | KILSDMRSQYEVMAE HHHHHHHHHHHHHHH | 30.40 | 26356563 | |
256 | Phosphorylation | LSDMRSQYEVMAEQN HHHHHHHHHHHHHHH | 16.25 | 26356563 | |
265 | Ubiquitination | VMAEQNRKDAEAWFT HHHHHHHHHHHHHHH | 69.69 | 21906983 | |
272 | Phosphorylation | KDAEAWFTSRTEELN HHHHHHHHHHHHHHH | 13.44 | 28348404 | |
273 | Phosphorylation | DAEAWFTSRTEELNR HHHHHHHHHHHHHHH | 27.94 | 27251275 | |
275 | Phosphorylation | EAWFTSRTEELNREV HHHHHHHHHHHHHHH | 33.31 | 27251275 | |
286 | Phosphorylation | NREVAGHTEQLQMSR HHHHCCCHHHHHCCH | 25.22 | 23312004 | |
292 | Phosphorylation | HTEQLQMSRSEVTDL CHHHHHCCHHHHHHH | 21.50 | 23312004 | |
294 | Phosphorylation | EQLQMSRSEVTDLRR HHHHCCHHHHHHHHH | 29.16 | 24719451 | |
302 | Phosphorylation | EVTDLRRTLQGLEIE HHHHHHHHHHHHHHH | 19.59 | 20068231 | |
312 | Phosphorylation | GLEIELQSQLSMKAA HHHHHHHHHHHHHHH | 45.79 | 20068231 | |
315 | Phosphorylation | IELQSQLSMKAALED HHHHHHHHHHHHHHH | 15.59 | 30278072 | |
317 | Ubiquitination | LQSQLSMKAALEDTL HHHHHHHHHHHHHHH | 27.42 | 21906983 | |
323 | Phosphorylation | MKAALEDTLAETEAR HHHHHHHHHHHHHHH | 20.63 | 28355574 | |
327 | Phosphorylation | LEDTLAETEARFGAQ HHHHHHHHHHHHHHH | 29.36 | 20860994 | |
343 | Phosphorylation | AHIQALISGIEAQLG HHHHHHHHCHHHHHC | 34.27 | 24719451 | |
370 | Ubiquitination | YQRLMDIKSRLEQEI HHHHHHHHHHHHHHH | 25.84 | 22817900 | |
371 | Phosphorylation | QRLMDIKSRLEQEIA HHHHHHHHHHHHHHH | 42.29 | 30087585 | |
379 | Phosphorylation | RLEQEIATYRSLLEG HHHHHHHHHHHHHCC | 25.73 | - | |
380 | Phosphorylation | LEQEIATYRSLLEGQ HHHHHHHHHHHHCCC | 6.81 | - | |
382 | Phosphorylation | QEIATYRSLLEGQED HHHHHHHHHHCCCHH | 27.22 | 26356563 | |
391 | Phosphorylation | LEGQEDHYNNLSASK HCCCHHHCCCCCHHH | 20.33 | 30278072 | |
395 | Phosphorylation | EDHYNNLSASKVL-- HHHCCCCCHHHCC-- | 32.40 | 24670416 | |
397 | Phosphorylation | HYNNLSASKVL---- HCCCCCHHHCC---- | 21.66 | 30278072 | |
398 | Ubiquitination | YNNLSASKVL----- CCCCCHHHCC----- | 47.47 | 21906983 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of K1C19_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of K1C19_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HGS_HUMAN | HGS | physical | 16189514 | |
DGC6L_HUMAN | DGCR6L | physical | 16189514 | |
SFI1_HUMAN | SFI1 | physical | 16189514 | |
ABI2_HUMAN | ABI2 | physical | 16189514 | |
PCM1_HUMAN | PCM1 | physical | 16189514 | |
DEPP_HUMAN | C10orf10 | physical | 16189514 | |
EXOC8_HUMAN | EXOC8 | physical | 16189514 | |
ZN638_HUMAN | ZNF638 | physical | 16189514 | |
USBP1_HUMAN | USHBP1 | physical | 16189514 | |
F107A_HUMAN | FAM107A | physical | 16189514 | |
KDM1A_HUMAN | KDM1A | physical | 23455924 | |
K1C19_HUMAN | KRT19 | physical | 25416956 | |
UBC9_HUMAN | UBE2I | physical | 25416956 | |
IF4E2_HUMAN | EIF4E2 | physical | 25416956 | |
RPAC1_HUMAN | POLR1C | physical | 25416956 | |
IKZF3_HUMAN | IKZF3 | physical | 25416956 | |
TFPT_HUMAN | TFPT | physical | 25416956 | |
TBCD7_HUMAN | TBC1D7 | physical | 25416956 | |
AMOL2_HUMAN | AMOTL2 | physical | 25416956 | |
CA109_HUMAN | C1orf109 | physical | 25416956 | |
4ET_HUMAN | EIF4ENIF1 | physical | 25416956 | |
CC146_HUMAN | CCDC146 | physical | 25416956 | |
CARD9_HUMAN | CARD9 | physical | 25416956 | |
F124B_HUMAN | FAM124B | physical | 25416956 | |
HAUS1_HUMAN | HAUS1 | physical | 25416956 | |
PPR18_HUMAN | PPP1R18 | physical | 25416956 | |
CE57L_HUMAN | CEP57L1 | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-97, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40, AND MASSSPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 AND SER-46, AND MASSSPECTROMETRY. | |
"Characterization of the major physiologic phosphorylation site ofhuman keratin 19 and its role in filament organization."; Zhou X., Liao J., Hu L., Feng L., Omary M.B.; J. Biol. Chem. 274:12861-12866(1999). Cited for: PHOSPHORYLATION AT SER-35, AND MUTAGENESIS OF SER-10 AND SER-35. | |
"Characterization of in vivo keratin 19 phosphorylation on tyrosine-391."; Zhou Q., Snider N.T., Liao J., Li D.H., Hong A., Ku N.O.,Cartwright C.A., Omary M.B.; PLoS ONE 5:E13538-E13538(2010). Cited for: PHOSPHORYLATION AT TYR-391. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-130, AND MASSSPECTROMETRY. |